ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 71 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51,361 | -11.6% | 19,679 | +21.2% | 0.00% | – |
| Q2 2023 | $58,133 | +47.8% | 16,239 | -10.1% | 0.00% | – |
| Q1 2023 | $39,332 | -85.4% | 18,056 | -19.6% | 0.00% | -100.0% |
| Q4 2022 | $270,000 | +67.7% | 22,459 | -9.1% | 0.00% | – |
| Q3 2022 | $161,000 | +83.0% | 24,701 | +28.6% | 0.00% | – |
| Q2 2022 | $88,000 | -35.8% | 19,203 | +17.4% | 0.00% | – |
| Q1 2022 | $137,000 | -63.5% | 16,354 | -37.7% | 0.00% | -100.0% |
| Q4 2021 | $375,000 | -2.8% | 26,267 | +49.5% | 0.00% | 0.0% |
| Q3 2021 | $386,000 | +282.2% | 17,570 | +131.5% | 0.00% | – |
| Q2 2021 | $101,000 | +110.4% | 7,588 | +60.6% | 0.00% | – |
| Q1 2021 | $48,000 | +1100.0% | 4,725 | +372.5% | 0.00% | – |
| Q4 2020 | $4,000 | +33.3% | 1,000 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Acrospire Investment Management LLC | 8,355 | $61,000 | 0.04% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 70,000 | $508,000 | 0.01% |
| Financial Architects, Inc | 2,000 | $15,000 | 0.00% |
| FineMark National Bank & Trust | 3,473 | $25,000 | 0.00% |
| JFS WEALTH ADVISORS, LLC | 1,000 | $7,000 | 0.00% |
| Penserra Capital Management LLC | 2,540 | $18,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,284 | $10,000 | 0.00% |
| SIMPLEX TRADING, LLC | 2,673 | $19,000 | 0.00% |
| Plante Moran Financial Advisors, LLC | 300 | $2,000 | 0.00% |
| Cutler Group LLC / CA | 2,404 | $17,000 | 0.00% |